Form 4 for URGN UroGen Pharma Ltd.

Accepted 2026-06-09 13:59:59 ET · period of report 2026-06-08 · accession 0001437749-26-019964 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-06-09 13:59	2026-06-08	URGN	Schoenberg Mark	Chief Medical Off	M - OptEx	—	+10.0K	145.0K	+7%	—
D	2026-06-09 13:59	2026-06-08	URGN	Schoenberg Mark	Chief Medical Off	S - Sale+OE	$27.30	-5,222	139.8K	-4%	-$142.6K
D	2026-06-09 13:59	2026-06-08	URGN	Schoenberg Mark	Chief Medical Off	M - OptEx	$0.00	-10.0K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2026-06-08	M	A	10,000	—	144,985	D	—	—	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
2	Common	Ordinary Shares	2026-06-08	S	D	5,222	$27.30	139,763	D	—	—	(F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
3	Derivative	Restricted Stock Units	2026-06-08	M	D	10,000	$0.00	0	D	— · — to —	10,000 Ordinary Shares	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F3) The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024. (F3) The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024.